Hepatitis B trials in China
103 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
No phaseRecruitingTrial-stage medicine
Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens
- Where
- Beijing, Shanghai
- Age
- 18 years to 80 years
- People
- 72
- Run by
- Huashan Hospital
See details and how to joinNCT06923280Registry updated 2026-07-29
Phase 2RecruitingTrial-stage medicine
A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
- Where
- Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Kunming, Shenzhen, Wuhan, Zunyi
- Age
- 18 years to 65 years
- People
- 200
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07069569Registry updated 2026-07-29
Phase 1RecruitingTrial-stage medicine
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
- Where
- Chengdu, Chongqing, Hangzhou, Shanghai, Zhengzhou
- Age
- 18 years to 65 years
- People
- 32
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07600788Registry updated 2026-07-29
Phase 2RecruitingTrial-stage medicine
A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Jiangmen, Kunming, Liuzhou, Meizhou, Nanchang, Nanjing, Qingyuan, Shanghai, Shenyang, Shenzhen, Wuhan, Xiamen, Xi’an, Yichang
- Age
- 18 years to 65 years
- People
- 320
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07635186Registry updated 2026-07-29
Phase 3RecruitingTrial-stage medicine
Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 540
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07606950Registry updated 2026-07-24
Phase 1RecruitingTrial-stage medicine
A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
- Where
- Ch’ang-ch’un, Hangzhou
- Age
- 18 years to 65 years
- People
- 110
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07511218Registry updated 2026-07-21
Phase 2RecruitingTrial-stage medicine
Study of AHB-171 in Chronic Hepatitis B Participants
- Where
- Beijing, Changzhou, Chengdu, Chongqing, Guangzhou, Hangzhou, Jilin City, Nanning, Xiamen, Zhengzhou
- Age
- 18 years to 65 years
- People
- 138
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07630727Registry updated 2026-07-21
Phase 2RecruitingTrial-stage medicine
Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
- Where
- Beijing
- Age
- 35 years to 65 years
- People
- 80
- Run by
- Fujian Akeylink Biotechnology Co., Ltd.
See details and how to joinNCT07709520Registry updated 2026-07-17
No phaseNot yet recruitingResearch participation
A Study on the Consistency Evaluation of Digital PCR Technology for Quantitative Detection of HBV Nucleic Acid
- Where
- Beijing
- Age
- 18 years and over
- People
- 200
- Run by
- Beijing Municipal Administration of Hospitals
See details and how to joinNCT07684209Registry updated 2026-07-07
Phase 1RecruitingTrial-stage medicine
A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
- Where
- Chengdu
- Age
- 18 years to 65 years
- People
- 9
- Run by
- Jiyan Liu
See details and how to joinNCT07051187Registry updated 2026-07-01
Phase 4Enrolling by invitationTrial-stage medicine
TAF in Early/Middle Pregnancy With CHB
- Where
- Guangzhou
- Age
- 20 years to 40 years
- People
- 816
- Run by
- The Third Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07668934Registry updated 2026-06-25
Phase 2RecruitingTrial-stage medicine
Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection
- Where
- Chongqing
- Age
- 18 years to 45 years
- People
- 45
- Run by
- Huahui Health
See details and how to joinNCT07519330Registry updated 2026-06-15
Early phase 1Not yet recruitingTrial-stage medicine
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
- Where
- Hangzhou, Ningbo
- Age
- 18 years to 65 years
- People
- 156
- Run by
- Ningbo No.2 Hospital
See details and how to joinNCT07553767Registry updated 2026-04-28
Phase 1RecruitingTrial-stage medicine
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
- Where
- Changsha
- Age
- 18 years to 60 years
- People
- 20
- Run by
- Sclnow Biotechnology Co., Ltd.
See details and how to joinNCT03826433Registry updated 2026-04-23
No phaseNot yet recruitingResearch participation
A Study on the Pursuit of Sustained Clearance of HBsAg in Chronic Hepatitis B(CHB) Patients With Previous Interferon Treatment Using Pegylated Interferon Alpha
- Where
- Shanghai
- Age
- 18 years to 65 years
- People
- 10,000
- Run by
- xieqing
See details and how to joinNCT07537387Registry updated 2026-04-17
No phaseRecruitingResearch participation
The Role and Regulatory Mechanism of Germinal Center Immune Response in Hepatitis B Virus Infection
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 280
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07240350Registry updated 2026-04-16
No phaseNot yet recruitingResearch participation
Union-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatitis B Patients
- Where
- Wuhan
- Age
- 18 years and over
- People
- 2,000
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07520123Registry updated 2026-04-09
No phaseRecruitingResearch participation
Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
- Where
- Guangzhou, Zhuhai
- People
- 16,300
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06966908Registry updated 2026-04-08
No phaseRecruitingResearch participation
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
- Where
- Shenyang
- Age
- 18 years to 80 years
- People
- 600
- Run by
- Shengjing Hospital
See details and how to joinNCT06779058Registry updated 2026-02-27
Phase 3Not yet recruitingTrial-stage medicine
A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
- Where
- Shanghai
- Age
- 18 years to 65 years
- People
- 1,208
- Run by
- Beijing Continent Pharmaceutical Co, Ltd.
See details and how to joinNCT07412236Registry updated 2026-02-17
Phase 1/2RecruitingTrial-stage medicine
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 76
- Run by
- Beijing Tuohua Weiye Biotechnology Co., Ltd.
See details and how to joinNCT07413549Registry updated 2026-02-17
Phase 3RecruitingTrial-stage medicine
To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 526
- Run by
- Fujian Akeylink Biotechnology Co., Ltd.
See details and how to joinNCT07090759Registry updated 2026-01-23
Early phase 1RecruitingTrial-stage medicine
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
- Where
- Beijing
- Age
- 18 years to 60 years
- People
- 132
- Run by
- Peking University People's Hospital
See details and how to joinNCT07328711Registry updated 2026-01-09
Phase 3RecruitingTrial-stage medicine
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
- Where
- Zhengzhou
- Age
- 18 years to 65 years
- People
- 120
- Run by
- Zhigang Ren
See details and how to joinNCT07307586Registry updated 2025-12-29
No phaseRecruitingResearch participation
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
- Where
- Jinan
- Age
- 18 years and over
- People
- 100
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07275554Registry updated 2025-12-10
All Hepatitis B trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.